Source: Newsday

Therasource: Biotech firm gets $3M to develop drug for radiation injury

TheraSource LLC, a Manhasset-based biotech spinoff of the Feinstein Institute for Medical Research, has received a $3 million grant from the National Institutes of Health to develop a treatment for radiation poisoning.

Read full article »
Therasource's Competitors | Therasource's News | Therasource's Financials
Stay up-to-date with the latest news on Therasource
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Ping Wang's photo - President of Therasource

President

Ping Wang

CEO Approval Rating

89/100

Read more
Stay up-to-date with the latest news on Therasource